Page last updated: 2024-11-02

pioglitazone and Dermatitis, Atopic

pioglitazone has been researched along with Dermatitis, Atopic in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research Excerpts

ExcerptRelevanceReference
"Pioglitazone is an oral antidiabetic drug."1.72Preparation and Evaluation of Polyvinylpyrrolidone Electrospun Nanofiber Patches of Pioglitazone for the Treatment of Atopic Dermatitis. ( Aljarrah, M; Hamed, R; Obaidat, R; Shameh, AA, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Obaidat, R1
Shameh, AA1
Aljarrah, M1
Hamed, R1

Other Studies

1 other study available for pioglitazone and Dermatitis, Atopic

ArticleYear
Preparation and Evaluation of Polyvinylpyrrolidone Electrospun Nanofiber Patches of Pioglitazone for the Treatment of Atopic Dermatitis.
    AAPS PharmSciTech, 2022, Jan-10, Volume: 23, Issue:1

    Topics: Dermatitis, Atopic; Drug Liberation; Humans; Nanofibers; Pioglitazone; Povidone

2022